Deficiency of tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) impairs nutritionally induced obesity in mice

Thrombosis and Haemostasis

Volumn 89, Issue 2, 2003, Pages 249-255

  Lijnen, H Roger ^a   Demeulemeester, Diego ^a   Van Hoef, Berthe ^a   Collen, Désiré ^a   Maquoi, Erik ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Adipose tissue; Angiogenesis; Obesity; TIMP 1; Tissue inhibitor of metalloproteinase 1

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEPTIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRIACYLGLYCEROL;

ADIPOCYTE; ADIPOSE TISSUE; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL; BLOOD VESSEL DIAMETER; BODY WEIGHT; CELL COUNT; CELL SPECIFICITY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME DEFICIENCY; GENE INACTIVATION; GENOTYPE; GLUCOSE BLOOD LEVEL; GONAD; HORMONE BLOOD LEVEL; LIPID DIET; MALE; MOUSE; NONHUMAN; NUTRITION; OBESITY; PRIORITY JOURNAL; STAINING; SUBCUTANEOUS FAT; TISSUE GROWTH; TISSUE INHIBITOR OF MATRIX METALLOPROTEINASE 1 DEFICIENCY; TREATMENT OUTCOME; TREATMENT PLANNING; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN; WILD TYPE;

EID: 0037327195     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613439     Document Type: Article

References (28)

1. Crandall DL, Hausman GJ, Kral JG. A review of the microcirculation of adipose tissue: Anatomic, metabolic, and angiogenic perspectives. Microcirculation 1997; 4: 211-32.
2. Dollery CM, McEwan JR, Henney AM. Matrix metalloproteinases and cardiovascular disease. Circ Res 1995; 77: 863-8.
3. Carmeliet P, Collen D. Development and disease in proteinase-deficient mice: Role of the plasminogen, matrix metallopreteinase and coagulation. Thromb Res 1998; 91: 255-85.
4. Lijnen HR. Molecular interactions between the plasminogen/plasmin and matrix metallo-proteinase systems. Fibrinolysis & Proteolysis 2000; 14: 175-81.
5. Brown LM, Fox HL, Hazen SA, LaNoue KF, Rannels SR, Lynch CJ. Role of the matrixin MMP-2 in multicellular organization of adipocytes cultured in basement membrane components. Am J Physiol 1997; 272: C937-49.
6. Lijnen HR, Maquoi E, Holvoet P, Mertens A, Lupu F, Morange P, Alessi MC, Juhan-Vague I. Adipose tissue expressin of gelatinases in mouse models of obesity. Thromb Haemost 2001; 85: 1111-1116.
7. Boulomié A, Sengés C, Portolan G, Galitzky J, Lafontan M. Adipocyte produces matrix metalloproteinase 2 and 9. Involvement in adipocyte differentiation. Diabetes 2001; 50: 2080-6.
8. Willenbrock F, Murphy G. Structure-function relationships in the tissue inhibitors of metalloproteinases. Am J Respir Crit Care Med 1994; 150: S165-70.
9. Greene J, Wang MS, Liu YLE, Raymond LA, Rosen C, Shi YNE. Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4. J Biol Chem 1996; 271: 30375-80.
10. Maquoi E, Munaut C, Colige A, Colen D, Lijnen HR. Modulation of the expression of murine matrix metalloproteinases and their tissue inhibitors with obesity. Diabetes 2002; 51: 1093-101.
11. Lijnen HR, Maquoi E, Demeulemeester D, Van Hoef B, Collen D. Modulation of fibrinolytic and gelatinolytic activity during adipose tissue development in a mouse model of nutritionally induced obesity. Thromb Haemost 2002; 88: 345-53.
12. Soloway PD, Alexander CM, Web Z, Jaenisch R. Targeted mutagenesis of TIMP-1 reveals that lung tumor invasion is influenced by TIMP-1 genotype of the tumor but not by that of the host. Oncogene 1996; 13: 2307-14.
13. Nothnick WB, Soloway P, Curry TE. Assessment of the role of tissue inhibitor of metallo-proteinase-1 (TIMP-1) during the periovulator period in female mice lacking a function-al TMP-1 gene. Biol Reprod 1997; 56: 1181-8.
14. Giles AR. Guidelines for the use of animals in biomedical research. Thromb Haemost 1987; 58: 1078-84.
15. Laitinen L. Griffonia simplicifolia lectins bind specifically to endothelial cells and some epithelial cells in mouse tissues. Histochem J 1987; 19: 225-34.
16. Lijnen HR, Van Hoef B, Lupu F, Moons L, Carmeliet P, Collen D. Function of plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes. Arterioscler Thromb Vasc Biol 1998; 18: 1035-45.
17. Kleiner DE, Stetler WG. Quantitative zymography: Detection of picogram quantities of gelatinases. Anal Biochem 1994; 218: 325-29.
18. Gallis ZS, Sukhova GK, Libby P. Microscopic localization of active proteases by in situ zymography: Detection of matrix metalloproteinase activity in vascular tissue. FASEB J 1995; 9: 974-80.
19. Decklerck PJ, Verstreken M, Collen D. Immunoassay of murine t-PA, u-PA and PAI-1 using monoclonal antibodies raised in gene-inactivated mice. Thromb Haemost 1995; 74: 1305-9.
20. Rogers P, Webb GP. Estimation of body fat in normal and obese mice. Br J Nutr 1980; 43: 83-6.
21. Lijnen HR, Maquoi E, Hansen LB, Van Hoef B, Frederix L, Collen D. Matrix metalloproteinase inhibition impairs adipose tissue development in mice. Arterioscler Thromb Vasc Biol 2002; 22: 374-9.
22. Rupnick MA, Panigrahy D, Zhang C-Y, Dallabrida SM, Lowell BB, Langer R, Folkman MJ. Adipose tissue mass can be regulated through the vasculature. Proc Natl Acad Sci USA 2002; 99: 10730-5.
23. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature 1998; 395: 763-70.
24. Maquoi E, Demeulemeester D, Vörös G, Collen D, Lijnen HR. Enhanced nutritionally induced adipose tissue development in mice with stromelysin-1 gene inactivation. Thromb Haemost 2003; 89 (in press).
25. Hlatky L, Hahnfeldt P, Folkman J. Clinical application of antiangiogenic therapy: Micro-vessel density, what it does and dosen't tell us. J Natl Cancer Inst 2002; 94: 883-93.
26. Cao R, Brakenhielm E, Wahlestedt C, Thyberg J, Cao Y. Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF. Proc Natl Acad Sci USA 2001; 98: 6390-5.
27. Hayakawa T, Yamashita K, Tanzawa K, Uchijima E, Iwata K. Growth-promoting activity of tissue inhibitor of metalloproteinase-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum. Febs Lett 1992; 298: 29-32.
28. Zhao WO, Li H, Yamashita K, Guo XK, Hoshino T, Yoshida S, Shinya T, Hayakawa T. Cell cycle-associated accumulation of tissue inhibitor of metalloproteinase-1 (TIMP-1) in the nuclei of human gingival fibroblasts. J Cell Sci 1998; 111: 1147-53.